BusinessImmuron Enrols First Patients in Clinical Study of IMM-529 for Treatment of Clostridium Difficile Infection (CDI)By Nasdaq OMXJan 31, 2018, 2:30 PM UTC
BusinessImmuron Approved to Commence Clinical Study in C.Difficile Infection (CDI)By Nasdaq OMXAug 9, 2017, 12:30 PM UTC
